Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer’s disease-Reference-Cited by-同舟云学术

Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer’s disease

Published:2010-05 Issue:4 Volume:113 Page:978-989
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:

Author:

Tian Guilian,Kong Qiongman,Lai Liching,Ray-Chaudhury Abhik,Lin Chien-liang G.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.2010.06661.x/fullpdf

Reference43 articles.

1. Lipid raft microdomains and neurotransmitter signalling;Allen;Nat. Rev. Neurosci.,2007

2. Interindividual differences in the levels of the glutamate transporters GLAST and GLT, but no clear correlation with Alzheimer’s disease;Beckstrom;J. Neurosci. Res.,1999

3. Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro;Bjorkhem;J. Biol. Chem.,1997

4. On the turnover of brain cholesterol in patients with Alzheimer’s disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells;Bogdanovic;Neurosci. Lett.,2001

5. Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function;Butchbach;J. Biol. Chem.,2004

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of pharmacogenetics of antiseizure medications: focusing on genetic variants of mechanistic targets;Frontiers in Pharmacology;2024-08-20

2. The glutamatergic system in Alzheimer’s disease: a systematic review with meta-analysis;Molecular Psychiatry;2024-02-16

3. Cholesterol and oxysterols in retinal neuron-glia interactions: relevance for glaucoma;Frontiers in Ophthalmology;2024-01-03

4. Systems pharmacology and multi-scale mechanism of Enicostema axillare bioactives in treating Alzheimer disease;Inflammopharmacology;2023-10-16

5. The potential of CYP46A1 as a novel therapeutic target for neurological disorders: An updated review of mechanisms;European Journal of Pharmacology;2023-06